Zeke Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -37.84%
- Profit Growth 0.89%
- Ebitda -0.29%
- Net Worth -85.27%
- Total Assets 21.55%
About Zeke Pharmaceuticals
Zeke Pharmaceuticals Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 December 2016 (Eight years and one month 19 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Laxmi Pujar and Chittannavar Raju serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24200KA2016PTC098367
- Company No.
098367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Zeke Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmi Pujar  | Director | 06-Dec-2021 | Current |
| Chittannavar Raju | Director | 08-Nov-2021 | Current |
Financial Performance of Zeke Pharmaceuticals.
Zeke Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 37.84% decrease. The company also saw a slight improvement in profitability, with a 0.89% increase in profit. The company's net worth observed a substantial decline by a decrease of 85.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeke Pharmaceuticals?
In 2018, Zeke Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cuzon Pharmaceuticals Private LimitedLaxmi Pujar and Chittannavar Raju are mutual person
- Zeke Advisors Private Limited
Laxmi Pujar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zeke Pharmaceuticals?
Unlock and access historical data on people associated with Zeke Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeke Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeke Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
